Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Keratosis, Actinic 22Cholangiocarcinoma 8Carcinoma, Basal Cell 8Carcinoma, Non-Small-Cell Lung 7Squamous Cell Carcinoma of Head and Neck 6Skin Neoplasms 4Bile Duct Neoplasms 4Pancreatic Neoplasms 3Mesothelioma, Malignant 3Lung Neoplasms 3Liver Neoplasms 3Leukoplakia, Oral 3Colorectal Neoplasms 3Warts 2Tongue Neoplasms 2Prostatic Neoplasms 2Pleural Diseases 2Neoplasms 2Neoplasm Metastasis 2Mycosis Fungoides 2Glioblastoma 2Esophageal Neoplasms 2Carcinoma, Squamous Cell 2Bowen's Disease 2Basal Cell Nevus Syndrome 2Barrett Esophagus 2Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1

Interventions

Gemcitabine 30Mitomycin 25BCG Vaccine 13Docetaxel 10Epirubicin 6erdafitinib 5durvalumab 5dodecyl maltoside 5Radiotherapy 5Cystoscopy 5apaziquone 4ALT-803 4tislelizumab 35-aminolevulinic acid hexyl ester 3viscum album peptide 2pembrolizumab 2disitamab vedotin 2avelumab 2VB4-845 2Therapeutics 2Imiquimod 2Hyaluronic Acid 2Administration, Intravesical 21-phenyl-3,3-dimethyltriazene 2vocimagene amiretrorepvec 1valrubicin 1tremelimumab 1toripalimab 1pirarubicin 1pemigatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Non-Muscle Invasive Bladder Neoplasms × Photochemotherapy × Clear all
NCT03053635 2018-08-20

Intravesical Photodynamic Therapy (PDT) in BCG Refractory High-Risk Non-muscle Invasive Bladder Cancer (NMIBC) Patients

TheralaseĀ® Technologies Inc.

Phase 1 Completed
6 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚔